Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intratumoral immune signature benefit from pembrolizumab: Results from a single-arm phase 2 trial

Tài liệu có liên quan:

• Ebook Frontiers in gynecological endocrinology (Volume 2: From basic science to clinical application): Part 2

  114 trang 39 0 0

• Association between metabolic syndrome and early-stage colorectal cancer

  9 trang 32 0 0

• Habitual tea consumption and 5-year incident metabolic syndrome among older adults: A community-based cohort study

  9 trang 32 0 0

• Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data

  11 trang 31 0 0

• Identification and characterization of a FOXA2-regulated transcriptional enhancer at a type 2 diabetes intronic locus that controls GCKR expression in liver cells

  14 trang 30 0 0

• Obesity: Physiologic changes and implications for preoperative management

  12 trang 29 0 0

• Is there an association between nonalcoholic fatty liver disease and cognitive function? A systematic review

  19 trang 28 0 0

• Circulating tumor cells in hepatocellular carcinoma: A pilot study of detection, enumeration, and next-generation sequencing in cases and controls

  11 trang 28 0 0

• MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells

  13 trang 28 0 0

• Analysis of the expression and prognostic significance of DDK complex in Hepatocarcinoma

  12 trang 28 0 0